ePrivacy and GPDR Cookie Consent by TermsFeed Generator

KANJINTI

150MG INF PLV CSL 1

SÚKL code 0222957
Name of the product KANJINTI
_MA_MEDICATION_DETAIL_INFO_MED_NAME i KANJINTI
Supplement 150MG INF PLV CSL 1
Strenght 150MG
Pharmaceutical form Powder for concentrate for solution for infusion
Package 1
Route Intravenous use
Wrap type Vial
Legal status na lékařský předpis
Active substance TRASTUZUMAB (TRASTUZUMABUM)
ATC group L01FD01
ATC group name TRASTUZUMAB

Marketing authorisation information

Registration Number EU/1/18/1281/001
Type of MA centralised without orphans
MA status R - active MA/authorised medicinal product
MA Holder Amgen Europe B.V., Breda
MA Holder country NIZOZEMSKO

Back to list